Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antinociceptive activity of the S1P-receptor agonist FTY720.
Coste O, Pierre S, Marian C, Brenneis C, Angioni C, Schmidt H, Popp L, Geisslinger G, Scholich K. Coste O, et al. Among authors: angioni c. J Cell Mol Med. 2008 Jun;12(3):995-1004. doi: 10.1111/j.1582-4934.2008.00160.x. J Cell Mol Med. 2008. PMID: 18494940 Free PMC article.
Dimethylcelecoxib inhibits prostaglandin E2 production.
Wobst I, Schiffmann S, Birod K, Maier TJ, Schmidt R, Angioni C, Geisslinger G, Grösch S. Wobst I, et al. Among authors: angioni c. Biochem Pharmacol. 2008 Jul 1;76(1):62-9. doi: 10.1016/j.bcp.2008.04.008. Epub 2008 Apr 24. Biochem Pharmacol. 2008. PMID: 18508034
The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grösch S. Schiffmann S, et al. Among authors: angioni c. Biochem Pharmacol. 2008 Jul 15;76(2):179-87. doi: 10.1016/j.bcp.2008.04.017. Epub 2008 May 4. Biochem Pharmacol. 2008. PMID: 18547544
Celecoxib inhibits 5-lipoxygenase.
Maier TJ, Tausch L, Hoernig M, Coste O, Schmidt R, Angioni C, Metzner J, Groesch S, Pergola C, Steinhilber D, Werz O, Geisslinger G. Maier TJ, et al. Among authors: angioni c. Biochem Pharmacol. 2008 Oct 1;76(7):862-72. doi: 10.1016/j.bcp.2008.07.009. Epub 2008 Jul 19. Biochem Pharmacol. 2008. PMID: 18692027
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis.
Schiffmann S, Sandner J, Schmidt R, Birod K, Wobst I, Schmidt H, Angioni C, Geisslinger G, Grösch S. Schiffmann S, et al. Among authors: angioni c. J Lipid Res. 2009 Jan;50(1):32-40. doi: 10.1194/jlr.M800122-JLR200. Epub 2008 Aug 18. J Lipid Res. 2009. PMID: 18711209 Free article.
Prostaglandin D(2) sustains the pyrogenic effect of prostaglandin E(2).
Gao W, Schmidtko A, Lu R, Brenneis C, Angioni C, Schmidt R, Geisslinger G. Gao W, et al. Among authors: angioni c. Eur J Pharmacol. 2009 Apr 17;608(1-3):28-31. doi: 10.1016/j.ejphar.2009.01.051. Epub 2009 Feb 26. Eur J Pharmacol. 2009. PMID: 19249295
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
Schiffmann S, Sandner J, Birod K, Wobst I, Angioni C, Ruckhäberle E, Kaufmann M, Ackermann H, Lötsch J, Schmidt H, Geisslinger G, Grösch S. Schiffmann S, et al. Among authors: angioni c. Carcinogenesis. 2009 May;30(5):745-52. doi: 10.1093/carcin/bgp061. Epub 2009 Mar 11. Carcinogenesis. 2009. PMID: 19279183
104 results